iCAD's ProFound Detection Version 4.0 Gets FDA Clearance
- Posted on November 12, 2024
- By Google News
- 1 Views
iCAD's ProFound Detection Version 4.0 Gets FDA Clearance
Nov. 12, 2024 — iCAD, Inc., a provider of clinically proven AI-powered cancer detection solutions, recently announced its ProFound Detection Version 4.0 for Digital Breast Tomosynthesis (DBT) has received clearance from the U.S. Food and Drug Administration (FDA).
